Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07849205) titled 'AnteAGE Exosomes and PEARL Multiplier With Microneedling for Facial Skin Quality' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Cellese Inc.
Condition:
Skin Aging
Skin Quality
Intervention:
Procedure: Mechanical microneedling
Other: AnteAGE Exosomes and PEARL Multiplier
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 2, 2025
Target Sample Size: 12
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/st...